[ad_1] Lucid’s quarterly revenue increased 392 percent sequentially Veris Health commercial expansion efforts underway, with next-generation Veris Cancer Care Platform launching in Q4 Conference call and webcast to be held…
Tag: PAVmed Inc.
PAVmed Provides Business Update and Second Quarter Financial Results
[ad_1] EsoGuard® test volume continues to grow as Lucid makes strides with commercial expansion and additional supporting data Veris Health prepares to launch the next generation of the Veris Cancer…